# Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism

> **NCT05794165** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Bryan Cotton** · enrollment: 314 (estimated)

## Conditions studied

- Trauma Injury
- Thromboembolism
- Venous Thromboembolism

## Interventions

- **DRUG:** Thrombate infusion
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05794165
- **Lead sponsor:** Bryan Cotton
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-09-27
- **Primary completion:** 2026-11
- **Final completion:** 2027-03
- **Target enrollment:** 314 (ESTIMATED)
- **Last updated:** 2025-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05794165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05794165, "Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05794165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*